Lynch on the GRANOLAS
This ranking weighs PEG ×4, Revenue growth ×3, ROE ×2, Analyst upside ×1, Buy % ×1, and nothing else, across the 11 companies we track on the GRANOLAS. 3 of them clear Lynch’s hard limits right now.
Ranked highest by Lynch on this market right now, which is not the same list as the one that clears the limits above:
- ASML (ASML) · Technology · PEG 1.47 · Revenue growth 21.3% · ROE 54% · Analyst upside 28.4% · Buy % 89%
- AstraZeneca (AZN) · Healthcare · PEG 1.28 · Revenue growth 6.4% · ROE 22% · Analyst upside 33.1% · Buy % 90%
- SAP (SAP) · Technology · PEG 1.64 · Revenue growth 9.4% · ROE 18% · Analyst upside 20.1% · Buy % 81%
- Roche (RHHBY) · Healthcare · PEG 1.49 · Revenue growth -1.2% · ROE 38% · Analyst upside 13.6% · Buy % 50%
- L'Oréal (LRLCY) · Consumer Defensive · PEG 2.31 · Revenue growth 5.8% · ROE 19% · Analyst upside 18.7% · Buy % 75%
From data as of 2026-09-11 01:00:55 UTC. Rebuilt every hour; the table above is live.